Cutting-Edge Nanocarrier-Based Strategies in the Management of Leukaemia

Cutting-edge Nanocarrier-based Strategies in the Management of Leukaemia addresses the growing importance of nanocarriers in leukaemia treatment. It explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. This book fills a critical gap in current literature, serving as a valuable resource for researchers, clinicians, and students. The book begins with an introduction to leukaemia, covering its epidemiology and risk factors. It then delves into innovative therapies and the use of various nanocarriers such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels. Additionally, it discusses precision medicine, AI in leukaemia care, and strategies to overcome treatment resistance, enriched with tables, figures, and images. Healthcare providers, including physicians, immunologists, oncologists, and pharmacists, will find this book invaluable. It educates on cutting-edge therapies and offers practical insights into personalized patient care, making it essential for those involved in leukaemia management.

• Provides an in-depth exploration of various nanocarrier-based therapies for leukaemia
• Integrates perspectives from multiple fields, such as nanotechnology, artificial intelligence, and personalized medicine, making it a valuable resource for a diverse audience including researchers, clinicians, and healthcare providers
• Enhances comprehension and provide practical insights, helping readers to better understand and apply the discussed therapies in clinical settings